Abstracts Accepted for Publication 2017
DOI: 10.1136/annrheumdis-2017-eular.4989 View full text |Buy / Rent full text
|
|

Abstract: BackgroundAnti-cyclic citrullinated peptide antibodies (Anti-CCP Ab) are well-established serological markers that show high sensitivity and specificity in diagnosing early rheumatoid arthritis (RA). Furthermore, Anti-CCP Ab is reported to be associated with bone erosions of RA. Therefore, Anti-CCP Ab positive RA patient can be a candidate for intensive treatment.ObjectivesUpper measurement limit of Anti-CCP Ab increased recently up to 1200 units. High level of Anti-CCP Ab may be a predictor of the profound th… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles